Showing 251-260 of 3157 results for "".
Octane Aesthetics Tech Forum: Guidepoint Qsight Managing Director Reveals New Medical Aesthetics Growth Data
https://modernaesthetics.com/conferences/octane-atf/octane-aesthetics-tech-forum-guidepoint-qsight-managing-director-reveals-new-medical-aesthetics-growth-data/33865/Modern Aesthetics caught up with Erik Haines, managing director for Guidepoint Qsight at Octane ATF. He details recently released data on the state of the $17.5 billion medical aesthetics industry.ASDS: Dr. Green on the Meeting
https://modernaesthetics.com/conferences/asds-annual-meeting/asds-dr-green-on-the-meeting/33841/Lawrence Green, MD, FAAD, discusses what makes the American Society for Dermatologic Surgery Annual Meeting special.Revision Skincare® hosts the third annual 2024 Elite Retreat in Dallas, TX
https://modernaesthetics.com/series/revision-skincare/elite-retreat-2024/33806/Chris Murray, VP of Strategic Partnerships, Revision Skincare; Tiphany Hall, PhD, MBA, Chief Growth Officer, Aesthetic Record; and Alex Sisler, Sr. Director of Strategic Accounts, Revision Skincare, share insights into the Elite Retreat meeting including how to attend, what makes it so unique, and tThe Partnership: Practice Findings & Value Adds
https://modernaesthetics.com/series/revision-skincare/the-partnership-practice-findings-value-adds/33741/This session rounds out the Elite Retreat seminars by sharing top practice analytics connected with value adds to ultimately aid in strategic planning for every practice’s future. AlexSandra Sisler, Sr. Director of Strategic Accounts - Revision Skincare® Scott Kera, Executive Vice President - AEVA DIn Focus: The Future of Aesthetics
https://modernaesthetics.com/topics/practice-development/in-focus-the-future-of-aesthetics/35204/An update on M&As and other practice trends that are shaping the specialtySolutions for Aesthetic Practice
https://modernaesthetics.com/topics/skincare/solutions-for-aesthetic-practice/35170/A look at new options to support aesthetic patientsAesthetic Treatments for Asian Patients
https://modernaesthetics.com/ma-issues-index/2016-sept-oct/aesthetic-treatments-for-asian-patients/34356/The growing Asian population and increasing demand for cosmetic procedures is creating both a need and an opportunity for core cosmetic physicians to develop expertise in treating this demographic.Octane Aesthetics Tech Forum: Combination Treatment Strategies May Evolve for Patients Using GLP-1 RAs
https://modernaesthetics.com/conferences/octane-atf-2026/octane-aesthetics-tech-forum-combination-treatment-strategies-may-evolve-for-patients-using-glp-1-ras/54706/Arash Moradzadeh, MD, founder of AM Facial Plastics, shares his perspective on aesthetic treatments and trends poised to disrupt the market in 2026. He discusses the expanding role of GLP-1 RA medications in aesthetics, including what’s on the horizon for these therapies.Harnessing PRF and Albumin
https://modernaesthetics.com/topics/regenerative-medicine/harnessing-prf-and-albumin/48723/The science behind aPRF and its role in regenerative aestheticsOctane Aesthetics Tech Forum: GLP-1 RAs, ‘Fat You Can Take Off the Shelf’ to Be Major Changes in 2026
https://modernaesthetics.com/conferences/octane-atf-2026/octane-aesthetics-tech-forum-glp-1-ras-fat-you-can-take-off-the-shelf-to-be-major-changes-in-2026/54708/Jonathan Kaplan, MD, MPH, Founder & CEO of DrWell, sat down with Modern Aesthetics at the 2026 Octane Aesthetics Tech Forum. As a panelist in the “GLPs and the Evolving Impact on Aesthetics” session, Dr. Kaplan explains what he believes will be disrupters to the industry this year, what is on th